V
Vext Science Inc
CNSX:VEXT
Vext Science Inc
CNSX:VEXT
Price:
0.28
CAD
1.82%
Market Closed
Market Cap:
CA$52m
Balance Sheet
Balance Sheet Decomposition
Vext Science Inc
Vext Science Inc
Balance Sheet Decomposition is not available for
Vext Science Inc
Vext Science Inc
Balance Sheet
Vext Science Inc
Vext Science Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
0
|
3
|
7
|
2
|
6
|
6
|
9
|
5
|
|
| Cash |
0
|
0
|
3
|
7
|
2
|
6
|
6
|
9
|
5
|
|
| Total Receivables |
5
|
9
|
14
|
17
|
20
|
24
|
22
|
8
|
2
|
|
| Accounts Receivables |
5
|
9
|
13
|
16
|
17
|
22
|
3
|
1
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
2
|
3
|
2
|
19
|
7
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
0
|
14
|
13
|
13
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
0
|
10
|
11
|
7
|
|
| Total Current Assets |
5
|
10
|
17
|
25
|
24
|
31
|
52
|
41
|
26
|
|
| PP&E Net |
2
|
3
|
4
|
9
|
13
|
29
|
36
|
41
|
39
|
|
| PP&E Gross |
2
|
3
|
4
|
9
|
13
|
29
|
36
|
41
|
39
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
2
|
3
|
6
|
10
|
13
|
17
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
8
|
7
|
28
|
62
|
64
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
|
| Note Receivable |
1
|
1
|
2
|
5
|
9
|
15
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
|
| Total Assets |
8
N/A
|
14
+68%
|
23
+69%
|
39
+65%
|
55
+43%
|
84
+51%
|
121
+44%
|
150
+24%
|
137
-8%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
4
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
2
|
2
|
2
|
1
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
6
|
6
|
6
|
6
|
5
|
|
| Other Current Liabilities |
0
|
1
|
1
|
0
|
0
|
0
|
6
|
4
|
6
|
|
| Total Current Liabilities |
1
|
1
|
3
|
2
|
9
|
10
|
16
|
14
|
18
|
|
| Long-Term Debt |
1
|
1
|
0
|
6
|
5
|
8
|
32
|
32
|
34
|
|
| Deferred Income Tax |
1
|
3
|
4
|
4
|
5
|
7
|
1
|
8
|
9
|
|
| Total Liabilities |
4
N/A
|
5
+42%
|
6
+27%
|
13
+104%
|
19
+46%
|
24
+27%
|
49
+100%
|
55
+12%
|
61
+12%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
4
|
10
|
17
|
34
|
34
|
53
|
53
|
|
| Retained Earnings |
5
|
9
|
13
|
16
|
19
|
26
|
38
|
42
|
20
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Equity |
5
N/A
|
9
+88%
|
17
+94%
|
26
+51%
|
36
+41%
|
59
+64%
|
72
+21%
|
95
+32%
|
76
-20%
|
|
| Total Liabilities & Equity |
8
N/A
|
14
+68%
|
23
+69%
|
39
+65%
|
55
+43%
|
84
+51%
|
121
+44%
|
150
+24%
|
137
-8%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
19
|
19
|
19
|
22
|
47
|
138
|
149
|
217
|
247
|
|
Switch to:
Switch to:
See Also
Discover More
